MaxWell Biosystems Company
MaxWell Biosystems provides solutions to advance basic neuroscience research and accelerate preclinical drug discovery. Its product MaxOne, electrophysiology platform for recording and stimulating electrogenic cells in vitro. It is a CMOS-based high-density microelectrode array with 26,400 electrodes, 1024 low-noise readout channels, and 32 stimulation channels. It allows extracting single cell and network parameters that facilitate phenotypic screening and drug toxicity/efficacy testing.
Register and Claim Ownership